BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15223930)

  • 21. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.
    Kanayama M; Hashimoto T; Shigenobu K; Yamane S; Bauer TW; Togawa D
    Spine (Phila Pa 1976); 2006 May; 31(10):1067-74. PubMed ID: 16648739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
    Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
    Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo evaluation of coralline hydroxyapatite and direct current electrical stimulation in lumbar spinal fusion.
    Bozic KJ; Glazer PA; Zurakowski D; Simon BJ; Lipson SJ; Hayes WC
    Spine (Phila Pa 1976); 1999 Oct; 24(20):2127-33. PubMed ID: 10543011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of low-intensity pulsed ultrasound on spinal pseudarthrosis created by nicotine administration: a model of lumbar posterolateral pseudarthrosis in rabbits.
    Liao JC; Chen WJ; Niu CC; Chen LH
    J Ultrasound Med; 2015 Jun; 34(6):1043-50. PubMed ID: 26014324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
    Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OP-1 Compared with Iliac Crest Autograft in Instrumented Posterolateral Fusion: A Randomized, Multicenter Non-Inferiority Trial.
    Delawi D; Jacobs W; van Susante JL; Rillardon L; Prestamburgo D; Specchia N; Gay E; Verschoor N; Garcia-Fernandez C; Guerado E; Quarles van Ufford H; Kruyt MC; Dhert WJ; Oner FC
    J Bone Joint Surg Am; 2016 Mar; 98(6):441-8. PubMed ID: 26984911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B2A peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft.
    Smucker JD; Bobst JA; Petersen EB; Nepola JV; Fredericks DC
    Spine (Phila Pa 1976); 2008 May; 33(12):1324-9. PubMed ID: 18496344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
    Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
    Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
    Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
    Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
    Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of insoluble bone gelatin as a carrier for enhancement of osteogenic protein-1-induced intertransverse process lumbar fusion in a rabbit model.
    Yao G; Qian Y; Chen J; Fan Y; Stoffel K; Yao F; Xu J; Zheng MH
    Spine (Phila Pa 1976); 2008 Aug; 33(18):1935-42. PubMed ID: 18708925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of a nanosynthetic bone graft substitute as a bone graft extender in rabbit posterolateral fusion.
    Conway JC; Oliver RA; Wang T; Wills DJ; Herbert J; Buckland T; Walsh WR; Gibson IR
    Spine J; 2021 Nov; 21(11):1925-1937. PubMed ID: 34033931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified bovine BMP extract and collagen for spine arthrodesis: preclinical safety and efficacy.
    Damien CJ; Grob D; Boden SD; Benedict JJ
    Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S50-8. PubMed ID: 12205421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
    Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study.
    Vaccaro AR; Lawrence JP; Patel T; Katz LD; Anderson DG; Fischgrund JS; Krop J; Fehlings MG; Wong D
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2850-62. PubMed ID: 19092614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerating autograft maturation in instrumented posterolateral lumbar spinal fusions without donor site morbidity.
    Rogozinski A; Rogozinski C; Cloud G
    Orthopedics; 2009 Nov; 32(11):809. PubMed ID: 19902899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions.
    Cook SD; Dalton JE; Tan EH; Whitecloud TS; Rueger DC
    Spine (Phila Pa 1976); 1994 Aug; 19(15):1655-63. PubMed ID: 7973957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.